
Iberdomide Shows Promise for Cutaneous Lupus in Phase 2 Study
Oct 31, 2024 · TOPLINE: Patients with cutaneous lupus erythematosus (CLE) experienced improved symptoms with iberdomide, a cereblon modulator, added to standard lupus …
Managing Cutaneous Vasculitis in a Patient With Lupus …
Sidebar: Case Study -- Cutaneous Vasculitis . The patient is a 47-year-old male with a 6-year history of systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome.
Managing Cutaneous Vasculitis in a Patient With Lupus …
Cite this: Managing Cutaneous Vasculitis in a Patient With Lupus Erythematosus - Medscape - Feb 01, 2007. Introduction Evaluation of Lesions and Patient Assessment
Neonatal Lupus Erythematosus - Page 4 - Medscape
Diseases & Conditions Subacute Cutaneous Lupus Erythematosus (SCLE) 2002 1094269-overview Diseases & Conditions ...
Emerging Therapies Foretell New Era for Cutaneous Disorders
Jan 25, 2024 · A study published in March 2023 of 11 patients showed that they had a "very fast response" to the agent, Fernandez said, with a 50% or greater improvement in the Cutaneous …
Cutaneous manifestations of systemic lupus erythematosus.
Jan 31, 2025 · Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Terbinafine-induced subacute cutaneous lupus erythematosus.
Jan 21, 2025 · Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Sunscreens good for UV-lupus - Medscape
Nov 17, 2004 · Modern sunscreens are very effective in preventing against ultraviolet-induced lupus erythematosus, German researchers have shown. (Herzinger T et al. 2004; 50: 3045 …
Cutaneous Hypertrophic Lupus Erythematosus - Medscape
Diseases & Conditions Subacute Cutaneous Lupus Erythematosus (SCLE) 2002 1065402-overview Diseases & Conditions ...
Anti-BDCA2 Antibody Meets Primary Endpoint in Phase 2 CLE Trial …
Aug 4, 2022 · Across 54 centers, the study enrolled 132 patients with primarily moderate-to-severe active subacute CLE or chronic CLE (including discoid lupus erythematosus), or both …